Evaluation of the Effect of Different Mesenchymal Stem Cell Microvesicles on Diabetic Wound Healing.
Kemaloğlu CA., Taşkın Ö., Gönen ZB., Yay AH., Bozkurt F.
Randomized Controlled Trial with a reported sample of 10 on Diabetic Foot, Chronic Wound, published in J Clin Pract Res (2026) — summary generated from the PubMed abstract.
Several human studies show positive signals, while research methods and sample sizes continue to develop.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Randomized Controlled Trial
- Journal
- J Clin Pract Res (2026)
- Country
- Turkey
- Reported sample size
- 10
- Source database
- PubMed
- PMID
- 41908353
- PMCID
- PMC13022841
- DOI
- 10.14744/cpr.2026.58278
Abstract (original English)
Objective Mesenchymal stem cell (MSC)-derived microvesicles play a pivotal role in the regenerative cascade of wound healing. This study aimed to comparatively evaluate the therapeutic potential of microvesicles isolated from different MSC sources in the healing of diabetic cutaneous wounds. Materials and methods Forty Wistar albino rats were randomly assigned to four experimental groups (n=10 per group). Following the induction of diabetes and the creation of full-thickness circular dorsal skin defects, each group received a distinct treatment: Group 1 received saline (control), Group 2 received adipose-derived stem cell microvesicles (ADSC-MVs), Group 3 received umbilical cord-derived stem cell microvesicles (UCDSC-MVs), and Group 4 received bone marrow-derived stem cell microvesicles (BMDSC-MVs). Outcomes related to re-epithelialization, neovascularization, and collagen matrix formation were evaluated both macroscopically and histologically. Results The microvesicle-treated groups demonstrated faster wound closure and improved collagen fiber alignment compared with the control group. Angiogenic activity was increased in all treatment groups, with the most pronounced effects observed in the UCDSC-MVs group. Notably, the UCDSC-MVs group exhibited a significantly greater epithelial tongue length than the control group on postoperative days 3 and 14 (p=0.008 and p Conclusion The
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Several human studies show positive signals, while research methods and sample sizes continue to develop.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level AMeta-analysisEurope PMC
Bone marrow-derived mesenchymal stem cells combined with intramuscular injection promote the healing of diabetic foot ulcers: a systematic review and meta-analysis
Meta-analysis with a reported sample of 2059 on Diabetic Foot, Chronic Wound, published in Front Endocrinol (Lausanne) (2026) — summary generated from the PubMed abstract.
- 2026
- n = 2059
Front Endocrinol (Lausanne) - Level AMeta-analysisEurope PMC
Comparative efficacy of advanced therapeutic modalities for diabetic foot ulcers: a systematic review and meta-analysis including NPWT, stem cells, ESWT, and bioengineered treatments
Meta-analysis on Diabetic Foot, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol - Level AMeta-analysisPubMed
Therapeutic potential of adipose-derived stem cells for diabetic foot ulcers: a systematic review and meta-analysis.
Meta-analysis on Diabetic Foot, Chronic Wound, published in Diabetol Metab Syndr (2025) — summary generated from the PubMed abstract.
- 2025
Diabetol Metab Syndr6 citations - Level AMeta-analysisPubMed
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus.
Meta-analysis on Diabetic Foot, Autoimmune Research, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Res Ther - Level AMeta-analysisEurope PMC
Comparison of the efficacy of 12 interventions in the treatment of diabetic foot ulcers: a network meta-analysis
Meta-analysis with a reported sample of 356 on Diabetic Foot, Chronic Wound, published in PeerJ (2025) — summary generated from the PubMed abstract.
- 2025
- n = 356
PeerJ1 citations